However, CCL17 is also expressed specifically by neutrophils and macrophages and plays a significant role in the alternative cross-priming of dendritic cells (DCs), enabling them to trigger CD8+ T lymphocyte responses against tumor antigens [44]. This evidence concerns the gene CCL17 and neoplasm.